Accueil>>Signaling Pathways>> Others>> Inhibitory Antibodies>>Feladilimab

Feladilimab (Synonyms: Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609)

Catalog No.GC69099

Feladilimab (anticorps monoclonal de référence anti-ICOS/CD278 (feladilimab); GSK3359609) est un IgG4 humanisé, un anticorps monoclonal contre l'activateur ICOS. Feladilimab se lie aux cellules T exprimant ICOS. Feladilimab a le potentiel d'être utilisé dans la recherche sur le cancer.

Products are for research use only. Not for human use. We do not sell to patients.

Feladilimab Chemical Structure

Cas No.: 2252518-85-5

Taille Prix Stock Qté
5mg
702,00 $US
En stock
10mg
1 125,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for Feladilimab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Feladilimab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.